We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
-23.07%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$99.3M
AUM Growth
-$32.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 94.07%
2 Communication Services 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$46.4M 46.79%
3,766,666
TVRD
2
Tvardi Therapeutics
TVRD
$23.5M
$42.2M 42.5%
88,696
LVO icon
3
LiveOne
LVO
$66M
$5.88M 5.93%
372,414
MRSN
4
DELISTED
Mersana Therapeutics
MRSN
$4.64M 4.68%
31,858
SENS icon
5
Senseonics Holdings Inc
SENS
$254M
$101K 0.1%
7,980

Similar funds

Rho Capital Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Rho Capital Partners held 5 positions worth $99.3M, down 25% from $132M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. Rho Capital Partners opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 96% a quarter earlier, followed by Communication Services.

  • Rho Capital Partners's ten largest holdings make up 100% of its $99.3M portfolio in Q1 2020.
  • Rho Capital Partners opened 0 new positions and closed 0 in Q1 2020.
  • Rho Capital Partners's portfolio value fell 25% quarter-over-quarter to $99.3M.

Based on Rho Capital Partners's 13F filing for Q1 2020, filed 13 May 2020.